HEADER HYDROLASE 26-APR-11 2LCB TITLE SOLUTION STRUCTURE OF A MINOR AND TRANSIENTLY FORMED STATE OF A T4 TITLE 2 LYSOZYME MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ENDOLYSIN, LYSIS PROTEIN, MURAMIDASE; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_TAXID: 10665; SOURCE 4 GENE: E; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET-29B KEYWDS EXCITED STATE, HYDROLASE EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR G.BOUVIGNIES,P.VALLURUPALLI,D.HANSEN,B.CORREIA,O.LANGE,A.BAH, AUTHOR 2 R.M.VERNON,F.W.DAHLQUIST,D.BAKER,L.E.KAY REVDAT 3 01-MAY-24 2LCB 1 REMARK SEQADV REVDAT 2 07-SEP-11 2LCB 1 JRNL REVDAT 1 17-AUG-11 2LCB 0 JRNL AUTH G.BOUVIGNIES,P.VALLURUPALLI,D.F.HANSEN,B.E.CORREIA,O.LANGE, JRNL AUTH 2 A.BAH,R.M.VERNON,F.W.DAHLQUIST,D.BAKER,L.E.KAY JRNL TITL SOLUTION STRUCTURE OF A MINOR AND TRANSIENTLY FORMED STATE JRNL TITL 2 OF A T4 LYSOZYME MUTANT. JRNL REF NATURE V. 477 111 2011 JRNL REFN ISSN 0028-0836 JRNL PMID 21857680 JRNL DOI 10.1038/NATURE10349 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE, CS-ROSETTA REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRPIPE), YANG SHEN, ROBERT VERNON, DAVID BAKER REMARK 3 AND AD BAX (CS-ROSETTA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CS-ROSETTA LOOP BUILDING REMARK 4 REMARK 4 2LCB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000102221. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : 85 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.5 MM [U-15N; U-2H] T4 L99A, REMARK 210 90% H2O/10% D2O; 1.5 MM [U-13C; REMARK 210 U-15N; U-2H] T4 L99A, 90% H2O/10% REMARK 210 D2O; 1.5 MM [U-13CA; U-15N] T4 REMARK 210 L99A, 100% D2O; 1.5 MM [U-13C; U- REMARK 210 15N; U-50% 2H] T4 L99A, 100% D2O; REMARK 210 1.5 MM [ U-15N] 13CH3 MET T4 REMARK 210 L99A, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 15N CT TROSY CPMG; 1H CT CPMG; REMARK 210 1H ZQ/DQ CPMG; 13C' CT CPMG; REMARK 210 13CA CT CPMG; 1HA CT CPMG; GLY REMARK 210 13CA CT CPMG; GLY 1HA CT CPMG; REMARK 210 1H-15N ZZ EXCHANGE; 1H-13C MET REMARK 210 ZZ EXCHANGE; 2D 1H-15N HSQC; 2D REMARK 210 1H-15N HMQC; 3D HNCO; 3D MQ HNCO; REMARK 210 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY, FUDA, CATIA, CS-ROSETTA REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 9600 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TWO STEP SELECTION CRITERIA REMARK 210 BASED ON CHEMICAL SHIFT SCORE REMARK 210 AND ROSETTA ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ILE A 29 72.53 -101.49 REMARK 500 2 ILE A 29 72.53 -101.49 REMARK 500 3 ILE A 29 72.53 -101.49 REMARK 500 4 ILE A 29 72.53 -101.49 REMARK 500 5 ILE A 29 72.53 -101.49 REMARK 500 6 ILE A 29 72.53 -101.49 REMARK 500 7 ILE A 29 72.53 -101.49 REMARK 500 8 ILE A 29 72.53 -101.49 REMARK 500 9 ILE A 29 72.53 -101.49 REMARK 500 9 PHE A 104 109.47 -53.31 REMARK 500 9 MET A 120 -38.12 -134.72 REMARK 500 10 ILE A 29 72.53 -101.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DMV RELATED DB: PDB REMARK 900 RELATED ID: 3DMX RELATED DB: PDB REMARK 900 RELATED ID: 17604 RELATED DB: BMRB REMARK 900 RELATED ID: 2LC9 RELATED DB: PDB DBREF 2LCB A 1 164 UNP P00720 LYS_BPT4 1 164 SEQADV 2LCB THR A 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 2LCB ALA A 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 2LCB ALA A 99 UNP P00720 LEU 99 ENGINEERED MUTATION SEQRES 1 A 164 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU GLY LEU SEQRES 2 A 164 ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR TYR THR SEQRES 3 A 164 ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SER LEU SEQRES 4 A 164 ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE GLY ARG SEQRES 5 A 164 ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA GLU LYS SEQRES 6 A 164 LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG GLY ILE SEQRES 7 A 164 LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SER LEU SEQRES 8 A 164 ASP ALA VAL ARG ARG ALA ALA ALA ILE ASN MET VAL PHE SEQRES 9 A 164 GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR ASN SER SEQRES 10 A 164 LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU ALA ALA SEQRES 11 A 164 VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN THR PRO SEQRES 12 A 164 ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG THR GLY SEQRES 13 A 164 THR TRP ASP ALA TYR LYS ASN LEU HELIX 1 1 ASN A 2 GLY A 12 1 11 HELIX 2 2 SER A 38 GLY A 51 1 14 HELIX 3 3 THR A 59 ARG A 80 1 22 HELIX 4 4 LYS A 83 LEU A 91 1 9 HELIX 5 5 ASP A 92 VAL A 103 1 12 HELIX 6 6 GLY A 107 GLN A 123 1 17 HELIX 7 7 ARG A 125 LYS A 135 1 11 HELIX 8 8 SER A 136 THR A 142 1 7 HELIX 9 9 THR A 142 GLY A 156 1 15 SHEET 1 A 3 ARG A 14 LYS A 19 0 SHEET 2 A 3 TYR A 25 GLY A 28 -1 O THR A 26 N TYR A 18 SHEET 3 A 3 HIS A 31 LEU A 32 -1 O HIS A 31 N ILE A 27 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1